TNFRSF8 and primary cutaneous T-cell non-Hodgkin lymphoma: BV is prescribed in adults for the treatment of Hodgkin lymphoma (HL), CD30+ HL, systemic anaplastic large cell lymphoma, and cutaneous T-cell lymphoma [40,41,42].